NCT05552339View on ClinicalTrials.gov

A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

August 18, 2023

Primary Completion Date

November 18, 2025

Study Completion Date

November 18, 2025

Conditions
Type 2 Diabetes MellitusChronic Kidney Disease
Interventions
DRUG

Finerenone (Kerendia, BAY94-8862)

Following the physicians' decision.

DRUG

Type 2 DM drugs

Following the physicians' decision

Trial Locations (1)

Unknown

RECRUITING

Many locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT05552339 - A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in a Group of Type 2 Diabetes Mellitus Patients | Biotech Hunter | Biotech Hunter